Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Helen Torley. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Helen Torley har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:HALO / Halozyme Therapeutics, Inc. PRESIDENT AND CEO, Director 733.719
US:DGX / Quest Diagnostics Incorporated Director 6.260
US:RLYP / Relypsa, Inc. Director 0
US:ONXX / Onyx Pharmaceuticals Inc EVP, Chief Commercial Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Helen Torley. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb HALO / Halozyme Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HALO / Halozyme Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-09-16 HALO Torley Helen 50.000 8,9200 50.000 8,9200 446.000 309 24.7500 791.500 177,47

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insidersalg HALO / Halozyme Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HALO / Halozyme Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-02-16 HALO Torley Helen 11.061 49,2600 11.061 49,2600 544.865 81 30.2800 -209.937 -38,53
2020-11-25 HALO Torley Helen 22.326 40,1740 22.326 40,1740 896.925
2020-11-25 HALO Torley Helen 27.674 41,1810 27.674 41,1810 1.139.643

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Helen Torley som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.300 733.719 -0,31 75,22 -173.015 55.193.278
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.800 736.019 -1,05 74,33 -579.751 54.706.084
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.900 743.819 -1,31 73,54 -728.006 54.697.474
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.500 733.719 -1,41 74,63 -783.636 54.758.916
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.500 744.219 -1,26 74,22 -705.090 55.235.934
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.412 733.719 -0,46 74,15 -252.990 54.403.063
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16.288 737.131 -2,16 73,70 -1.200.393 54.325.080
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -300 753.419 -0,04 72,48 -21.746 54.611.576
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.052 733.719 -0,68 64,83 -327.511 47.565.535
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -14.948 738.771 -1,98 64,14 -958.839 47.388.466
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.958 733.719 -0,94 64,00 -445.319 46.958.750
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -13.042 740.677 -1,73 63,24 -824.802 46.841.895
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.283 733.719 -0,17 63,60 -81.596 46.663.061
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18.717 735.002 -2,48 63,01 -1.179.321 46.311.006
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15.746 733.719 -2,10 57,62 -907.237 42.274.688
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.254 749.465 -0,56 56,74 -241.380 42.526.143
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -208 733.719 -0,03 57,08 -11.872 41.877.746
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -19.792 733.927 -2,63 56,43 -1.116.783 41.412.565
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16.402 733.719 -2,19 55,74 -914.215 40.896.030
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.598 750.121 -0,48 54,48 -196.030 40.868.842
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15.511 733.719 -2,07 53,91 -836.214 39.555.525
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.489 749.230 -0,60 53,11 -238.406 39.790.856
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-06-24 2025-06-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -20.000 733.719 -2,65 52,57 -1.051.460 38.573.809
2025-06-24 2025-06-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-06-24 2025-06-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -20.000 733.719 -2,65 52,96 -1.059.200 38.857.758
2025-06-24 2025-06-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20.000 753.719 2,73 8,11 162.200 6.112.661
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -12.081 733.719 -1,62 57,75 -697.678 42.372.272
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 22.436 745.800 3,10
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9.087 723.364 -1,24 58,29 -529.681 42.164.888
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16.875 732.451 2,36
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -11.313 715.576 -1,56 58,29 -659.435 41.710.925
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21.009 726.889 2,98
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -38.668 705.880 -5,19 58,29 -2.253.958 41.145.745
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 71.810 744.548 10,67
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -7.098 672.738 -1,04 58,29 -413.742 39.213.898
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13.092 679.836 1,96
2024-12-03 2024-11-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10.000 666.744 -1,48
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.404 676.744 -0,35 53,91 -129.590 36.480.562
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.615 679.148 -0,24 53,31 -86.096 36.205.380
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.981 680.763 -0,87 51,85 -310.097 35.295.519
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -900 676.744 -0,13 54,57 -49.116 36.931.950
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.100 677.644 -1,33 53,94 -490.845 36.551.440
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-26 2024-09-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 56,10 -560.970 37.963.308
2024-09-26 2024-09-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-26 2024-09-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 56,34 -563.370 38.125.727
2024-09-26 2024-09-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-26 2024-09-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 58,21 -582.100 39.393.268
2024-09-26 2024-09-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-12 2024-09-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 59,20 -592.030 40.065.275
2024-09-12 2024-09-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-12 2024-09-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 59,09 -590.870 39.986.773
2024-09-12 2024-09-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-09-12 2024-09-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 59,09 -590.890 39.988.126
2024-09-12 2024-09-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-08-15 2024-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 57,95 -579.490 39.216.638
2024-08-15 2024-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -200 676.744 -0,03 58,17 -11.634 39.366.198
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.537 676.944 -0,96 57,73 -377.394 39.081.331
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.263 683.481 -0,48 56,22 -183.443 38.424.618
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-08-15 2024-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 676.744 -1,46 56,25 -562.490 38.066.173
2024-08-15 2024-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 686.744 1,48 13,87 138.700 9.525.139
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9.070 676.744 -1,32 36,10 -327.427 24.430.458
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16.875 685.814 2,52
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -11.292 668.939 -1,66 36,10 -407.641 24.148.698
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21.009 680.231 3,19
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17.619 659.222 -2,60 35,91 -632.698 23.672.662
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 32.781 676.841 5,09
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -7.036 644.060 -1,08 35,91 -252.663 23.128.195
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13.092 651.096 2,05
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16.943 638.004 -2,59 35,49 -601.307 22.642.762
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31.281 654.947 5,02
2023-08-31 2023-08-31 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,82 -428.170 26.703.507
2023-08-31 2023-08-31 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-08-31 2023-08-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,85 -428.540 26.726.583
2023-08-31 2023-08-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-08-31 2023-08-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,40 -424.020 26.444.686
2023-08-31 2023-08-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-08-17 2023-08-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 43,18 -431.820 26.931.145
2023-08-17 2023-08-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-08-17 2023-08-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 43,53 -435.320 27.149.428
2023-08-17 2023-08-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-08-17 2023-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 43,77 -437.680 27.296.613
2023-08-17 2023-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-07-27 2023-07-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 43,79 -437.900 27.310.334
2023-07-27 2023-07-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-07-27 2023-07-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,69 -426.890 26.623.678
2023-07-27 2023-07-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-07-27 2023-07-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,80 -427.960 26.690.410
2023-07-27 2023-07-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 13,87 138.700 8.788.947
2023-03-09 2023-03-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 42,73 -427.270 26.647.377
2023-03-09 2023-03-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 14,66 146.600 9.289.544
2023-03-09 2023-03-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 43,26 -432.590 26.979.167
2023-03-09 2023-03-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 14,66 146.600 9.289.544
2023-03-09 2023-03-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 623.666 -1,58 45,47 -454.690 28.357.469
2023-03-09 2023-03-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 633.666 1,60 14,66 146.600 9.289.544
2023-03-01 2023-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10.000 623.666 -1,58
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -11.061 633.666 -1,72 49,26 -544.865 31.214.387
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21.010 644.727 3,37
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -6.892 623.717 -1,09 49,20 -339.086 30.686.876
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13.092 630.609 2,12
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17.266 617.517 -2,72 48,92 -844.653 30.208.932
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32.794 634.783 5,45
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16.469 601.989 -2,66 48,92 -805.663 29.449.302
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31.281 618.458 5,33
2023-02-09 2023-02-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 50,40 -504.000 29.593.721
2023-02-09 2023-02-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2023-02-09 2023-02-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 51,36 -513.570 30.155.649
2023-02-09 2023-02-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2023-02-09 2023-02-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 51,26 -512.580 30.097.519
2023-02-09 2023-02-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2023-01-19 2023-01-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 52,41 -524.140 30.776.295
2023-01-19 2023-01-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2023-01-19 2023-01-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 51,05 -510.470 29.973.624
2023-01-19 2023-01-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.103 587.177 -0,19 50,93 -56.175 29.904.337
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.897 588.280 -1,49 50,40 -448.364 29.646.371
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -896 587.177 -0,15 58,20 -52.145 34.171.940
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.104 588.073 -1,52 57,29 -521.550 33.689.526
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-12-15 2022-12-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 58,30 -582.980 34.231.245
2022-12-15 2022-12-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -493 587.177 -0,08 59,12 -29.146 34.713.904
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.507 587.670 -1,59 58,64 -557.481 34.460.381
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-11-17 2022-11-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 52,15 -521.490 30.620.693
2022-11-17 2022-11-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-11-17 2022-11-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 587.177 -1,67 53,90 -538.990 31.648.253
2022-11-17 2022-11-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -13 587.177 0,00 54,60 -710 32.062.800
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.987 587.190 -1,67 54,11 -540.437 31.775.200
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 597.177 1,70 14,66 146.600 8.754.615
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 84.037 84.037
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 257.046 257.046
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -13.092 39.276 -25,00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -6.892 587.177 -1,16 34,43 -237.292 20.216.504
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13.092 594.069 2,25
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28.729 0 -100,00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -15.125 580.977 -2,54 33,64 -508.805 19.544.066
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28.729 596.102 5,06
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32.795 32.794 -50,00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17.266 567.373 -2,95 34,20 -590.497 19.404.157
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32.795 584.639 5,94
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -31.282 62.562 -33,33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16.598 551.844 -2,92 34,94 -579.934 19.281.429
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31.282 568.442 5,82
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50.000 150.000 -25,00 14,66 -733.000 2.199.000
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.225 537.160 -2,23 40,42 -494.122 21.711.470
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -37.775 549.385 -6,43 39,62 -1.496.646 21.766.634
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50.000 200.000 -20,00 14,66 -733.000 2.932.000
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.857 537.160 -1,08 40,95 -239.862 21.998.313
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -44.143 543.017 -7,52 39,97 -1.764.528 21.706.019
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50.000 250.000 -16,67 14,66 -733.000 3.665.000
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.560 537.160 -1,21 42,98 -281.942 23.086.600
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -43.440 543.720 -7,40 42,29 -1.836.904 22.991.744
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50.000 300.000 -14,29 14,66 -733.000 4.398.000
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.048 537.160 -0,19 46,11 -48.323 24.768.448
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -500 538.208 -0,09 44,91 -22.454 24.169.845
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -400 538.708 -0,07 43,26 -17.304 23.304.508
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.000 539.108 -0,19 42,64 -42.640 22.987.565
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21.914 540.108 -3,90 41,47 -908.752 22.397.739
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -25.138 562.022 -4,28 40,42 -1.016.103 22.717.491
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 350.000 -12,50 14,66 -733.000 5.131.000
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50.000 537.160 -8,52 45,97 -2.298.650 24.694.857
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 400.000 -11,11 14,66 -733.000 5.864.000
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50.000 537.160 -8,52 39,66 -1.982.950 21.303.228
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-05-25 2021-05-25 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1.363 6.260 27,83
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 450.000 -10,00 14,66 -733.000 6.597.000
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.066 537.160 -0,20 44,84 -47.803 24.087.866
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.956 538.226 -0,73 44,10 -174.479 23.738.458
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -36.522 542.182 -6,31 43,05 -1.572.236 23.340.393
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.456 578.704 -1,44 42,17 -356.581 24.403.369
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 500.000 -9,09 14,66 -733.000 7.330.000
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50.000 537.160 -8,52 42,54 -2.127.250 22.853.472
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 550.000 -8,33 14,66 -733.000 8.063.000
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -33.890 537.160 -5,93 46,48 -1.575.112 24.965.693
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16.110 571.050 -2,74 45,58 -734.342 26.030.172
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 587.160 9,31 14,66 733.000 8.607.766
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -39.354 0 -100,00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19.511 537.160 -3,50 48,69 -949.991 26.154.320
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 39.354 556.671 7,61
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 52.368 52.368
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 90.134 90.134
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28.729 28.729 -50,00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -14.243 517.317 -2,68 49,84 -709.871 25.783.079
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28.729 531.560 5,71
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32.795 65.589 -33,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16.259 502.831 -3,13 49,84 -810.349 25.061.097
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32.795 519.090 6,74
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -31.282 93.844 -25,00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -15.509 486.295 -3,09 50,60 -784.755 24.606.527
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31.282 501.804 6,65
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 600.000 -7,69 14,66 -733.000 8.796.000
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.437 470.522 -1,14 48,51 -263.736 22.823.893
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -44.563 475.959 -8,56 47,76 -2.128.182 22.730.231
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50.000 520.522 10,63 14,66 733.000 7.630.853
2020-11-30 2020-11-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10.000 470.522 -2,08
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50.000 650.000 -7,14 14,66 -733.000 9.529.000
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -27.674 480.522 -5,45 41,18 -1.139.643 19.788.376
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -22.326 508.196 -4,21 40,17 -896.925 20.416.266
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 50.000 530.522 10,41 14,66 733.000 7.777.453
2020-08-14 2020-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10.000 480.522 -2,04
2020-05-21 2020-05-19 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1.531 4.897 45,48
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -39.354 39.354 -50,00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19.511 490.522 -3,83 21,83 -425.925 10.708.095
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 39.354 510.033 8,36
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28.730 57.458 -33,33
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -14.244 470.679 -2,94 21,10 -300.548 9.931.327
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28.730 484.923 6,30
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32.795 98.384 -25,00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16.259 456.193 -3,44 20,00 -325.180 9.123.860
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32.795 472.452 7,46
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 125.126 125.126
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 266.051 266.051
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -55.487 0 -100,00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19.910 439.657 -4,33 19,21 -382.471 8.445.811
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 55.487 459.567 13,73
2020-02-04 2019-12-19 5 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -12.500 404.080 -3,00
2019-05-16 2019-05-14 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1.722 3.366 104,74
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -39.354 78.708 -33,33
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19.511 416.580 -4,47 16,81 -327.980 7.002.710
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 39.354 436.091 9,92
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -28.730 86.188 -25,00
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -14.244 396.737 -3,47 16,54 -235.596 6.562.030
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 28.730 410.981 7,52
2019-02-14 2019-02-12 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 131.179 131.179
2019-02-14 2019-02-12 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 250.218 250.218
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31.250 0 -100,00
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -14.547 382.251 -3,67 16,73 -243.371 6.395.059
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31.250 396.798 8,55
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55.487 55.487 -50,00
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19.425 365.548 -5,05 16,12 -313.131 5.892.634
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55.487 384.973 16,84
2018-10-03 2018-10-01 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 1.298 1.298
2018-07-05 2018-07-02 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 1.297 1.297
2018-06-05 2018-06-01 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 665 665
2018-05-17 2018-05-15 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1.644 1.644
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -39.354 118.062 -25,00
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19.511 329.486 -5,59 19,28 -376.172 6.352.490
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 39.354 348.997 12,71
2018-02-16 2018-02-14 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 114.918 114.918
2018-02-16 2018-02-14 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 201.552 201.552
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31.250 31.250 -50,00
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -15.493 309.643 -4,77 18,25 -282.747 5.650.985
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31.250 325.136 10,63
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55.487 110.974 -33,33
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -24.111 293.886 -7,58 18,37 -442.919 5.398.686
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55.487 317.997 21,14
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30.000 0 -100,00
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11.649 262.510 -4,25 19,46 -226.690 5.108.445
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30.000 274.159 12,29
2017-02-24 2017-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 157.416 157.416
2017-02-24 2017-02-22 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 251.923 251.923
2017-02-07 2017-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31.250 62.500 -33,33
2017-02-07 2017-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31.250 244.159 14,68
2017-02-06 2017-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55.487 166.461 -25,00
2017-02-06 2017-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55.487 212.909 35,25
2017-01-09 2017-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30.000 30.000 -50,00
2017-01-09 2017-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30.000 157.422 23,54
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4.500 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4.500 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -12.000 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
D - Sale to Issuer -2.250 0 -100,00 32,00 -72.000
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
U - Other -1.237 2.250 -35,47 32,00 -39.584 72.000
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Performance Stock Units
M - Exercise -13.500 0 -100,00
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Performance Stock Units
A - Award 13.500 13.500
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -7.044 127.422 -5,24 8,63 -60.790 1.099.652
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 13.500 134.466 11,16
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
A - Award 4.500 4.500
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Common Stock
A - Award 2.250 3.487 181,89
2016-06-08 2016-06-07 4 RLYP Relypsa Inc
Common Stock
S - Sale -1.013 1.237 -45,02 19,32 -19.570 23.897
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31.250 93.750 -25,00
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11.743 120.966 -8,85 7,90 -92.770 955.631
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31.250 132.709 30,80
2016-02-04 2016-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 221.948 221.948
2016-02-04 2016-02-03 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 376.569 376.569
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30.000 60.000 -33,33
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11.686 101.459 -10,33 15,77 -184.288 1.600.008
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30.000 113.145 36,08
2016-01-04 2015-12-31 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -16.436 83.145 -16,51 17,33 -284.836 1.440.903
2016-01-04 2015-12-31 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 31.500 99.581 46,27
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 4.500 4.500
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Common Stock
A - Award 2.250 2.250
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 125.000 125.000
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 200.000 200.000
2015-01-26 2015-01-22 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 12.000 12.000
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30.000 90.000 -25,00
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11.919 68.081 -14,90 10,06 -119.905 684.895
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30.000 80.000 60,00
2014-09-16 2014-09-16 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
P - Purchase 50.000 50.000 8,92 446.000 446.000
2014-01-08 2014-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 120.000 120.000
2014-01-08 2014-01-06 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 700.000 700.000 14,66 10.262.000 10.262.000
2014-01-08 3 HALO HALOZYME THERAPEUTICS INC
Common Stock
0
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -24.300 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -12.156 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -1.144 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -44.132 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -11.868 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -28.575 0 -100,00 125,00 -3.571.875
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -7.336 28.575 -20,43 125,00 -917.000 3.571.875
2013-09-05 2013-09-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
F - Taxes X -2.099 35.911 -5,52 123,62 -259.478 4.439.318
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1.250 13.300 -8,59
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7.000 56.000 -11,11
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1.061 46.585 -2,23 126,92 -134.667 5.912.801
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8.250 47.646 -14,76 126,89 -1.046.810 6.045.615
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1.250 55.896 2,29 37,68 47.100 2.106.161
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7.000 54.646 14,69 33,70 235.900 1.841.570
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1.250 14.450 -7,96
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7.000 63.000 -10,00
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1.000 47.646 -2,06 97,26 -97.260 4.634.055
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -2.500 48.646 -4,89 98,28 -245.690 4.780.739
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -3.000 51.146 -5,54 98,78 -296.352 5.052.406
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1.750 54.146 -3,13 97,32 -170.308 5.269.413
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7.000 55.896 14,32 33,70 235.900 1.883.695
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1.250 48.896 2,62 37,68 47.100 1.842.401
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -466 47.646 -0,97 86,14 -40.141 4.104.226
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.300 24.300
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 8.600 48.112 21,77
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1.250 15.800 -7,33
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7.000 70.000 -9,09
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8.250 39.512 -17,27 78,61 -648.532 3.106.038
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1.250 47.762 2,69 37,68 47.100 1.799.672
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7.000 46.512 17,72 33,70 235.900 1.567.454
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1.250 17.050 -6,83
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7.000 77.000 -8,33
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -11.997 39.512 -23,29 75,22 -902.414 2.972.093
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1.250 51.509 2,49 37,68 47.100 1.940.859
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7.000 50.259 16,18 33,70 235.900 1.693.728
2012-10-05 2012-10-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -2.314 43.259 -5,08 86,51 -200.184 3.742.336
2012-09-06 2012-09-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1.878 56.823 -3,20 72,78 -136.681 4.135.578
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -2.000 58.701 -3,29 71,89 -143.780 4.220.015
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -4.549 60.701 -6,97 73,97 -336.498 4.490.168
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 18.300 18.300
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 17.150 65.250 35,65
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 3.600 48.100 8,09
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)